181 related articles for article (PubMed ID: 29638100)
21. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
[TBL] [Abstract][Full Text] [Related]
22. Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
Allen RP
Int Rev Psychiatry; 2014 Apr; 26(2):248-62. PubMed ID: 24892899
[TBL] [Abstract][Full Text] [Related]
23. Restless Leg Syndrome and Sleep Disorders in Patients with Rheumatoid Arthritis and Its Relation with Anemia Parameters.
Demir S; Kucuk A; Altas M; Cure E
Acta Medica (Hradec Kralove); 2021; 64(3):137-144. PubMed ID: 34779378
[TBL] [Abstract][Full Text] [Related]
24. Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.
Stevens MS
Sleep Med Clin; 2015 Sep; 10(3):369-73, xv-xvi. PubMed ID: 26329447
[TBL] [Abstract][Full Text] [Related]
25. Differential Diagnoses of Restless Legs Syndrome/Willis-Ekbom Disease: Mimics and Comorbidities.
Chokroverty S
Sleep Med Clin; 2015 Sep; 10(3):249-62, xii. PubMed ID: 26329435
[TBL] [Abstract][Full Text] [Related]
26. Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.
Rinaldi F; Galbiati A; Marelli S; Cusmai M; Gasperi A; Oldani A; Zucconi M; Padovani A; Ferini Strambi L
J Neurol; 2016 Feb; 263(2):396-402. PubMed ID: 26725086
[TBL] [Abstract][Full Text] [Related]
27. Quantitative sensory test for primary restless legs syndrome/Willis-Ekbom disease using the current perception threshold test.
Cho YW; Kang MS; Kim KT; Do SY; Lim JG; Lee SY; Motamedi GK
Sleep Med; 2017 Feb; 30():19-23. PubMed ID: 28215248
[TBL] [Abstract][Full Text] [Related]
28. Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Ferini-Strambi L; Carli G; Casoni F; Galbiati A
Front Neurol; 2018; 9():551. PubMed ID: 30087647
[TBL] [Abstract][Full Text] [Related]
29. What patients do to counteract the symptoms of Willis-Ekbom disease (RLS/WED): Effect of gender and severity of illness.
Gupta R; Goel D; Ahmed S; Dhar M; Lahan V
Ann Indian Acad Neurol; 2014 Oct; 17(4):405-8. PubMed ID: 25506161
[TBL] [Abstract][Full Text] [Related]
30. Sensorimotor white matter projections and disease severity in primary Restless Legs Syndrome/Willis-Ekbom disease: a multimodal DTI analysis.
de Paiva JPQ; Magalhães SC; Moura LM; Sato JR; Amaro E; Sterr A; Schlaffke L; Eckeli AL; do Prado GF; Conforto AB
Sleep Med; 2020 Sep; 73():106-116. PubMed ID: 32805477
[TBL] [Abstract][Full Text] [Related]
31. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
[TBL] [Abstract][Full Text] [Related]
32. Restless legs syndrome/Willis Ekbom disease: new diagnostic criteria according to different nosology.
Marelli S; Galbiati A; Rinaldi F; Giora E; Oldani A; Ferini Strambi L; Zucconi M
Arch Ital Biol; 2015; 153(2-3):184-93. PubMed ID: 26742672
[TBL] [Abstract][Full Text] [Related]
33. Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).
Rinaldi F; Galbiati A; Marelli S; Ferini Strambi L; Zucconi M
Curr Treat Options Neurol; 2016 Feb; 18(2):7. PubMed ID: 26874840
[TBL] [Abstract][Full Text] [Related]
34. An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment.
Garcia-Borreguero D; Williams AM
Curr Opin Neurol; 2014 Aug; 27(4):493-501. PubMed ID: 24978636
[TBL] [Abstract][Full Text] [Related]
35. Psychological distress in patients with restless legs syndrome (Willis-Ekbom disease): a population-based door-to-door survey in rural Ecuador.
Castillo PR; Mera RM; Fredrickson PA; Zambrano M; Del Brutto VJ; Del Brutto OH
BMC Res Notes; 2014 Dec; 7():911. PubMed ID: 25510187
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of restless legs syndrome/Willis Ekbom Disease (RLS/WED) among people living at high altitude in the Indian Himalaya.
Gupta R; Ulfberg J; Allen RP; Goel D
Sleep Med; 2017 Jul; 35():7-11. PubMed ID: 28619185
[TBL] [Abstract][Full Text] [Related]
37. Association of BST1 polymorphism with idiopathic restless legs syndrome in Chinese population.
Huang Y; Wang P; Luo Q; Ma J
Sleep Breath; 2021 Dec; 25(4):1987-1993. PubMed ID: 33625657
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A
de Almeida CMO; Brito MMC; Bosaipo NB; Pimentel AV; Sobreira-Neto MA; Tumas V; Zuardi AW; Crippa JAS; Hallak JEC; Eckeli AL
Cannabis Cannabinoid Res; 2023 Apr; 8(2):374-378. PubMed ID: 35749710
[No Abstract] [Full Text] [Related]
39. F-Wave Duration as a Specific and Sensitive Tool for the Diagnosis of Restless Legs Syndrome/Willis-Ekbom Disease.
Congiu P; Fantini ML; Milioli G; Tacconi P; Figorilli M; Gioi G; Pereira B; Marrosu F; Parrino L; Puligheddu M
J Clin Sleep Med; 2017 Mar; 13(3):369-375. PubMed ID: 28095964
[TBL] [Abstract][Full Text] [Related]
40. Restless legs syndrome in pediatric onset multiple sclerosis.
Yalcinkaya BC; Amirov CB; Saltik S; Senel GB
Mult Scler Relat Disord; 2021 Nov; 56():103295. PubMed ID: 34624645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
